IL-6 and TNF-α production during active canine visceral leishmaniasis

Veterinary Immunology and Immunopathology

Volumn 115, Issue 1-2, 2007, Pages 189-193

  de Lima, Valeria M F ^a   Peiro, Juliana Regina ^a   de Oliveira Vasconcelos, Rosemeri ^a  

^a Faculdade de Medicina Veterinaria de Aracatuba   (Brazil)

Author keywords

Cytokine; IL 6; Leishmania (Leishmania) chagasi; TNF ; Visceral leishmaniasis

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; APATHY; ARTICLE; BRAZIL; CACHEXIA; CONJUNCTIVITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DERMATITIS; DOG; EDEMA; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTAXIS; FEMALE; FEVER; HEPATOSPLENOMEGALY; HYPERGAMMAGLOBULINEMIA; LEISHMANIA CHAGASI; LOCOMOTION; LYMPHADENOPATHY; MALE; NAIL DISEASE; NONHUMAN; SEROLOGY; STUDENT T TEST; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION;

ANIMALS; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-6; LEISHMANIASIS, VISCERAL; MALE; TUMOR NECROSIS FACTOR-ALPHA;

CANIS FAMILIARIS; LEISHMANIA DONOVANI CHAGASI;

EID: 33845396264     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.10.003     Document Type: Article

References (19)

1. Akuffo H.O., and Britton S.F. Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans. Clin. Exp. Immunol. 87 (1992) 58-64
2. Alvar J., Canavate C., Molina R., Moreno J., and Nieto J. Canine leishmaniasis. Adv. Parasitol. 57 (2004) 1-88
3. Barral-Netto M., Badaró R., Barral A., Almeida R.P., Santos S.B., Badaró F., Pedral-Sampaio D., Carvalho E.M., Falcoff E., and Falcoff R. Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J. Infect. Dis. 163 (1991) 853-857
4. Caldas A., Favali C., Aquino D., Vinhas V., Van Weyenbergh J., Brodskyn C., Costa J., Barral-Netto M., and Barral A. Balance of IL-10 and Interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect. Dis. 19 (2005) 113-117
5. Cenini P., Berhe N., Hailu A., McGinnes K., and Frommel D. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J. Infect. Dis. 168 (1993) 986-993
6. Chamizo C., Moreno J., and Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet. Immunol. Immunopathol. 103 (2005) 67-75
7. Cortes S., Rolao N., Ramada J., and Campino L. PCR as a rapid and sensitive tool in the diagnosis of human and canine leishmaniasis using Leishmania donovani s.1.-specific kinetoplastid primers. Trans. Soc. Trop. Med. Hyg. 98 (2004) 12-17
8. Dalrymple S.A., Lucian L.A., Slattery R., McNeil T., Aud D.M., Fuchino S., Lee F., and Murray R. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63 (1995) 2262-2268
9. De Beaux A.C., and Fearon K.C. Circulating endotoxin, tumour necrosis factor-alpha, and their natural antagonists in the pathophysiology of acute pancreatitis. Scand. J. Gastroenterol. Suppl. 219 (1996) 43-47
10. Dye C. The logic of visceral leishmaniasis control. Am. J. Trop. Med. Hyg. 55 (1996) 125-130
11. Le J.M., and Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61 (1989) 588-602
12. Lima V.M.F., Gonçalves M.E., Ikeda F.A., Luvizotto M.C.R., and Feitosa M.M. Anti-leishmania antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis. Braz. J. Med. Biol. Res. 36 (2003) 485-489
13. Martinez-Subiela S., Bernal L.J., and Ceron J.J. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment. Am. J. Vet. Res. 64 (2003) 1021-1026
14. Moreno J., and Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 18 (2002) 399-405
15. Pinelli E., Killick-Kendrick R., Wagennaar J., Bernadina W., Real G., and Ruitenberg E.J. Cellular and humoral immune response in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62 (1994) 229-235
16. Riera C., Valladares J.E., and Gállego M. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Vet. Parasitol. 84 (1999) 33-47
17. Scheerlinck J.Y. Funcional and Structural comparasion of cytokines in different species. Vet. Immunol. Immunopathol. 72 (1999) 39-44
18. Van Der Poll T., Zijlstra E.E., and Mevissen M. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin. Immunol. Immunophatol. 77 (1995) 111-114
19. Voller A., Bidwell D.E., and Bartlett A. Enzyme-linked immunosorbent assay. In: Rose N., and Friedman H. (Eds). Manual of Clinical Immunology (1980), American Society for Microbiology, Washington, DC, USA 359-371